:max_bytes(150000):strip_icc()/GettyImages-2167560261-141f5295ac5d423a9b7cd0f2edc2d76a.jpg?#)
Stock Radar: Aurobindo Pharma stock showing signs of momentum after 30% fall from highs; what should investors do?
Aurobindo Pharma rebounded after testing Rs 1,000 in September 2025, reclaiming short-term moving averages. Experts suggest high-risk traders buy with a target of Rs 1,300 in a couple of months. The stock is consolidating, and a break above its 200 DEMA could induce fresh momentum. Gradual accumulation between Rs 1,050-1,120 is recommended.
Aurobindo Pharma rebounded after testing Rs 1,000 in September 2025, reclaiming short-term moving averages. Experts suggest high-risk traders buy with a target of Rs 1,300 in a couple of months. The stock is consolidating, and a break above its 200 DEMA could induce fresh momentum. Gradual accumulation between Rs 1,050-1,120 is recommended.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
